Communiqués Organogenesis Holdings Inc.

Actions

ORGO

US68621F1021

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
3,09 ^USD	+6,92 %		+11,15 %	-24,45 %

13/05	ORGANOGENESIS HOLDINGS INC. : Morgan Stanley maintient sa recommandation neutre	ZM
09/05	Transcript : Organogenesis Holdings Inc., Q1 2024 Earnings Call, May 09, 2024

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024	15/07	AQ
Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference	06/06	AQ
Spotlight: Healthcare and Tech VTAK, ORGO, CDIO, LAZR, VLCN	14/05	AQ
Organogenesis: Q1 Earnings Snapshot	09/05	AQ
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results	09/05	AQ
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis	02/05	AQ
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024	16/04	AQ
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case	03/04	AQ
Organogenesis: Q4 Earnings Snapshot	29/02	AQ
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance	29/02	AQ
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference	12/02	AQ
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024	08/02	AQ
HippoFi Hires World's Top Regenerative Therapy Expert, Dr. Gail Naughton, to Drive Commercialization Plans of its Proprietary Technologies	12/12	AQ
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	07/12	BU
Organogenesis: Q3 Earnings Snapshot	09/11	AQ
Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results	09/11	AQ
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023	05/10/23	AQ
Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS	28/09/23	AQ
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference	06/09/23	AQ
Organogenesis: Q2 Earnings Snapshot	09/08/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Organogenesis Holdings Inc.

Actions

ORGO

US68621F1021

Communiqués

Filtres